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Abstract Analyses of energy metabolism in human cancer
have been difficult because of rapid turnover of the
metabolites and difficulties in reducing time for collecting
clinical samples under surgical procedures. Utilization of
xenograft transplantation of human-derived colon cancer
HCT116 cells in spleens of superimmunodeficient NOD/
SCID/IL-2Rγ
null (NOG) mice led us to establish an
experimental model of hepatic micrometastasis of the solid
tumor, whereby analyses of the tissue sections collected by
snap-frozen procedures through newly developed microscop-
ic imaging mass spectrometry (MIMS) revealed distinct
spatial distribution of a variety of metabolites. To perform
intergroup comparison of the signal intensities of metabolites
among different tissue sections collected from mice in fed
states, we combined matrix-assisted laser desorption/ioniza-
tion time-of-flight imaging mass spectrometry (MALDI–
TOF-IMS) and capillary electrophoresis–mass spectrometry
(CE–MS), to determine the apparent contents of individual
metabolites in serial tissue sections. The results indicated
significant elevation of ATP and energy charge in both
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To note were significant increases in UDP-N-acetyl hexos-
amines, and reduced and oxidized forms of glutathione in the
metastatic foci versus the liver parenchyma. These findings
thus provided a potentially important method for character-
izing the properties of metabolic systems of human-derived
cancer and the host tissues in vivo.
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Introduction
Imaging mass spectrometry (IMS) has enabled us to collect
spatial information about a variety of biomolecules, for
example phospholipids [1, 2], drugs [3], peptides [4, 5],
and metabolites [6–8] in tissue sections in situ. Many kinds
of ion sources for imaging mass spectrometry had been
developed in recent years. For example, ultraviolet matrix-
assisted laser desorption/ionization (MALDI) is capable of
producing ions from low-molecular-mass compounds, being
promising for imaging volatile compounds in fresh ginger
samples [9]. Low-molecular-mass metabolites have also been
analyzed by other methods including desorption electrospray
ionization and desorption/ionization on silicon [10, 11]. In
these methods, samples should be dried before image
acquisition of metabolomic snapshots to avoid enzymatic
degradation of the molecule of interest. On the other hand,
laser ablation electrospray ionization or infrared MALDI are
other useful methods of molecular imaging that are applicable
to water-rich specimens to ionize the analytes [12, 13].
In order to acquire reliable images of metabolites in and
around cancers in vivo, several lines of methodological
consideration are necessary. First, enzymatic reactions in
tissue and cell samples should be terminated as soon as
possible. Second, soft ionization of the molecules seemed
desirable to identify individual peaks of metabolites.
Finally, high spatial resolution at cellular levels is required
to examine differences in metabolic properties between the
cancer foci and the surrounding host tissues. In this context,
application of ultraviolet MALDI to freeze-dried tissue
samples is suitable for examining cancer metabolism in
vivo. Regarding the spatial resolution of the ultraviolet
MALDI, the raster scan pitch of the laser application has
been restricted by its focusing diameter, in the approximate
range 50–200 μm[ 7, 8]. Our newly developed UV–
MALDI–quadrupole ion-trap (QIT)-TOF-MS instrument,
that is, a mass microscope with 10-μm spatial resolution,
overcame this problem of spatial resolution by improvement
of the ion source to control the position of the sample stage
three-dimensionally withhigh accuracy [9, 14, 15]. Using 9-
aminoacridine as a matrix, metabolites, such as high-energy
nucleotides and phosphorylated carbohydrates became
directly detectable in frozen tissue sections [6]. Since then,
various types of tissues including brain and muscles of
mice have been analyzed experimentally to dissect molec-
ular mechanisms for metabolic systems in vivo [7, 8, 16].
The objective of this study was to characterize metabolic
systems in and around human-derived solid tumors in vivo.
Although distinct properties of cancer metabolism known
as Warburg effects have been examined mainly in cultured
systems or conventional animal experiments, there are
several technical difficulties in characterizing the metabo-
lism of human solid tumors in vivo. First, it is difficult to
shorten the time for sampling of tissues to avoid degrada-
tion of metabolites with rapid turnover under surgical
procedures. Second, because of large variances of the mass
intensities of molecules among individual tissue samples, a
method to semi-quantify their signals and to compare these
among individual samples should be developed. To
overcome the first problem, we have herein utilized an
experimental model of xenograft transplantation of human-
derived colon cancer HCT 116 cell line in superimmuno-
deficient NOD/SCID/IL-2Rγ
null (NOG) mice [17]. In this
model, we were able to collect snap-frozen samples of the
tumor-bearing liver for analyses by using imaging mass
spectrometry with high spatial resolution. To solve the
second problem, we used serial sections of the liver to
determine total amounts of individual metabolites, using
CE–MS for data calibration. This method enabled us to
carry out intergroup comparison of semi-quantitative
metabolite data in and around micrometastases of the
human-derived colon cancer. Results obtained in this study
revealed that the tumor-bearing liver accelerates its energy
metabolism. Furthermore, several metabolites including
UDP-N-acetyl hexosamine (UDP-HexNAc) and glutathione,
and the value of energy charge were significantly elevated in
the metastatic foci, suggesting significance of these mole-
cules as marker metabolites enriched in the cancer in vivo.
Experimental
Chemicals
9-Aminoacridine (9-AA) was purchased from Merck
Schuchardt (Hohenbrunn, Germany). All chemical stan-
1896 A. Kubo et al.dards were obtained from common commercial sources and
dissolved in Milli-Q (Millipore) water, 0.1 mol L
−1 HCl, or
0.1 mol L
−1 NaOH to furnish 10 mmol L
−1 or
100 mmol L
−1 stock solutions. Distilled water purified by
use of a Milli-Q water system was used for all the
preparations. Working standard mixtures were prepared by
diluting stock solutions with Milli-Q water immediately
before injection of samples for CE–MS analysis. The
chemicals used were analytical or reagent grades.
Animal model to observe growth of human-derived cancer
in vivo
Care and use of laboratory animals were in accordance with
the Experimental Animal Committee of Keio University
School of Medicine which followed the Guidelines for the
Proper Conduct of Animal Experiments by the Science
Council of Japan. We herein applied an experimental model
using superimmunodeficient NOD/SCID/IL-2Rγ
null (NOG)
mice [18] which lack T-cells, B-cells, and NK cells,
enabling xenograft transplantation of the human-derived
colon cancer cell line HCT116 transfected with venus,a
GFP-mutant gene (HCT116/venus) was injected intraspleni-
cally as described elsewhere [17, 19]. Toour knowledge,the
system using NOG mice serves as a reliable experimental
model in which human-derived cancer cell lines transplanted
in vivo generate metastases forming solid tumors in organs
includingtheliverinvivowithgreaterreproducibilitythanthe
conventional model using NOD mice which lack T-cells and
B-cells but not NK cells [17]. In the intrasplenic implantation
model using HCT116/venus, micrometastases of the cancer
occurred mostly in periportal regions of the liver within one
week, extending their size over the following three weeks
[19]. In this study, male mice at 11–13 weeks were fed with
Laboratory chow and allowed free access to water. They
were anesthetized by use of pentobarbital sodium, and their
abdominal walls were cut to exteriorize the portion of the
liver lobules for snap-frozen procedures using liquid nitrogen
as described elsewhere [20, 21]. The livers of the xenograft-
transplanted NOG mice used for the analyses were collected
under fed conditions two weeks after the xenograft trans-
plantation, unless otherwise mentioned.
Tissue preparation
A schematic diagram of a standard experimental design
typical of tissue section application can be seen in the
Electronic Supplementary Material (Fig. S1). The liver
tissues snap-frozen in liquid nitrogen were dissected to
prepare cryosections with 5-μm thickness by use of a
cryostat (CM 1900; Leica Microsystems, Wetzlar, Ger-
many). The sections were thaw-mounted on indium–tin
oxide (ITO) slides (8–12 ohm/sq; Sigma, Chiba, Japan) and
were dried in silica gel-containing plastic tubes then sprayed
with 9-aminoacridine (9-AA, 20 mg in 4 mL 70% MeOH) by
use of a 0.2-mm nozzle caliber airbrush (Procon boy FWA
Platinum; Mr Hobby, Tokyo, Japan) to conduct MALDI–IMS
in negative ion mode. Adjacent sections were fixed with 10%
buffered formalin (Nacalai Tesque, Kyoto, Japan) and stained
with the Masson trichrome staining reagent kit according to
the manufacturer’s procedures (Muto Pure Chemicals, Tokyo,
Japan). The other frozen tissues were used for metabolome
analyses using CE–MS.
Instruments
An atmospheric pressure MALDI–QIT-TOF-MS equipped
with a 355-nm Nd:YAG laser and a built-in fluorescence
microscope furnished mass images with high spatial
resolution of 10 μm, as described for a prototype IMS
machine [9] (Mass Microscope; Shimadzu, Kyoto, Japan).
The microscopewasalsoequippedwitha 120-W metal halide
light source (X-Cite 120PC-Q; Lumen Dynamics Group,
Ontario, Canada) and a fluorescence mirror unit (U-
MGFPHQ; Olympus, Tokyo, Japan) that enabled us to
visualize venus-associated green fluorescence from meta-
static foci in tissue slices before matrix application. This
system thus enabled us to collect both fluorescence images
and mass images from the same tissue slices. Before
applying matrices, a fluorescence image of the analyte was
acquired and followed by recording the location of the
specimen on the XYZ stage. ITO slides with the sample
holder were removed from the XYZ stage, and sprayed
uniformly with 4 mL 9-AA solution. After application of the
matrix, the sample holder was placed back on the XYZ stage,
which was adjusted to exactly the same location. The mass
spectra of the designated areas on a specimen photographed
before matrix application were acquired in the negative-ion
mode. The data collected through the microscopic system
were digitally processed according to the method described
later, in the section “Determination of the apparent contents
of metabolites based on data calibration by CE–MS”.
Experiments using capillary electrophoresis electrospray
ionization mass spectrometry (CE–MS) were performed with
a capillary electrophoresis system equipped with an air
pressure pump, MSD quadrupole MS, isocratic HPLC pump,
and CE–MS adapter kit (Agilent Technologies, Waldbronn,
Germany) [20, 22]. All system control, data acquisition, and
MSD data evaluation were performed using Agilent G2201A
ChemStation software for CE–MSD.
Conditions for MALDI imaging and tandem MS analyses
All the MALDI imaging experiments and tandem MS
experiments were carried out in negative-ion mode using a
prototype mass microscope. The laser power was adjusted
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acquired under the conditions laser frequency 800 Hz and
scanning mass range from m/z 260 to m/z 900. Regions of
the tissue samples exposed to the laser irradiation were
determined by light and fluorescence microscopic observa-
tions. A raster scan on the tissue surface was performed
automatically (250×250 spots per scan). Laser irradiation
was repeated 160 times for the individual spots. The spatial
interval of data points was 10 μm, giving 62,500 data
points in total for each section. Tandem MS analyses were
performed to determine the structures of metabolites at
appropriate laser energy, argon gas percentage, and
collision-induced dissociation (CID) energy conditions. To
identify metabolites detected in MALDI–IMS, we searched
the Human Metabolome Database (http://hmdb.ca)a n d
performed tandem MS analyses, comparing the tandem
mass spectra with those from standard reagents using 9-AA
as the matrix of choice in negative mode. The distribution of
biomolecules that were identifies by MS
2 analysis were
visualized as mass images using BioMap software (http://
www.maldi-msi.org) from Novartis (Basel, Switzerland).
Determination of the apparent contents of metabolites
based on data calibration by CE–MS
To compare differences in contents of many different
metabolites in multiple tissue slices collected from different
subjects, we conducted CE–MS-based metabolome analy-
ses of tissue lysates collected from the same snap-frozen
liver samples for IMS. As reported previously [20–22],
CE–MS enabled us to quantitatively determine more than
2,000 different metabolites at once in small amounts of a
single liver sample. Small amounts of the frozen tissue were
collected from thick section that was adjacent to the section for
IMS. The CE–MS samples weighing approximately 300 mg
wet weight was ground using a multi-bead shocker (model
MB755U; Yasui Kikai, Osaka, Japan) with frozen metal
granules, and 1 mL methanol containing internal standards
(300 μmol L
−1 each of L-methionine sulfone and 2-
morpholinoethanesulfonic acid (MES)) was added. After
addition of 0.5 mL deionized water and 1 mL chloroform,
the mixture was centrifuged at 15,000 rpm for 15 min at 4 °C.
Theupperaqueouslayerofthesamplewasfilteredthroughthe
5-kDa cutoff filter (Millipore, Tokyo, Japan) by centrifugation
to remove protein components. The filtrate was lyophilized
and dissolved in 200 μL deionized water containing reference
compounds (200 μmol L
−1 each of 3-aminopyrrolidine and
trimesate). The amounts of metabolites were normalized by
liver weight of the original tissue samples. Assuming that
1 mg wet tissue was equivalent to 1 μL, apparent contents of
individual metabolites were calculated for the data calibration
in imaging mass microscopy by computer-assisted data
processing in the later session.
To semi-quantify apparent contents of individual metab-
olites mapped on the images, regions of interest (ROIs) for
the cancer xenografts and the liver parenchyma were
selected by careful visual inspection of fluorescence and
light microscopic images. Averaged spectra from each ROI
were generated and statistically analyzed by use of the
laboratory-written software SIMtools (Shimadzu Imaging
Mass spectrometry toolbox for MATLAB). The Mann–
Whitney U-test was used to compare the ion signal
intensity between the tumor and the liver parenchyma.
To calculate apparent contents of metabolites in IMS, mass
signals covering m/z between 260 and 620 were collected
from 250×250 spots on a tissue sample. Direct comparison of
metabolite ion signals among different slices requires realistic
transformation of acquired mass signals of a metabolite in
absolute terms, for example tissue contents in nmol g
−1 tissue.
To that effect, apparent contents of a specific metabolite in the
ROI designated as liver parenchyma ([CLiver]app )o rt u m o r
([CTumor]app ) were calculated by use of Eqs. 1, 2,a n d3:
CTumor ½  app ¼ CAverage

  ITumor=IAverage

ð1Þ
CLiver ½  app ¼ CAverage

  ILiver=IAverage

ð2Þ
IAverage ¼ ILiver   OLiver ðÞ =100
þ ITumor   OTumor ðÞ =100 ð3Þ
where [CAverage] denotes the amount of a metabolite of
interest in the whole tissue section for IMS (nmol g
−1 tissue).
ITumor, ILiver, and IAverage are MALDI signal intensities
measured in regions of tumor metastases, liver parenchyma,
and the whole tissue section, respectively. OTumor and OLiver
are the percentage areas of tumor regions and liver
parenchyma, respectively, in tumor-bearing livers. These
indices were designated by the green fluorescence intensities
acquired by fluorescence microscopy of the whole frozen
section using Image J software (NIH, http://rsbweb.nih.gov/
ij/index.html). Assuming that percentages of tumor-bearing
regions in the tissue sections are comparable with those of
the metastases in the adjacent tissue samples for the CE–MS
measurements, the values of [CAverage] can be replaced by
[CCE–MS], the amounts of the metabolites of interest in the
tissue samples for CE–MS, as seen in Eqs. 1′ and 2′.
CTumor ½  app ¼ CCE MS ½    ITumor=IAverage

ð1′Þ
CLiver ½  app ¼ CCE MS ½    ILiver=IAverage

ð2′Þ
In order to calculate the values for [CTumor]app and
[CLiver]app, ITumor, ILiver, and IAverage were determined in
1898 A. Kubo et al.three different ROIs in a single tissue specimen, while the
corresponding value of [CCE–MS] was collected from a
portion of the tissue adjacent to the samples for IMS. A set
of mass-imaging data paired with CE–MS data in a single
animal were repeated for four separate animals.
To construct an ion-content map, data collected by
MALDI–QIT-MS were saved and digitally processed to
be converted to Analyze format, a common multidimen-
sional biomedical imaging format file. The Analyze format
file was processed to construct an ion-content map, where
the relationship between the apparent content of a metab-
olite of interest at a pixel “i” (Ci) and the MALDI signal
intensity in the same pixel (I(i)) was expressed by Eq. 4:
Ci ¼ CCE MS ½    IðiÞ=IAverage

ð4Þ
Validation of the calibrated data in IMS by analysis
of high-energy adenylates in vivo
Reliability of the calibrated data seemed to depend on
multiple factors including the quality of CE–MS-based
metabolome analysis and that of tissue-sampling proce-
dures in the snap-frozen processes. In accordance with our
previous studies [7], we determined apparent contents of
ATP, ADP, and AMP by IMS combined with CE–MS.
Based on these data, apparent energy charge of individual
pixels were calculated by use of Eq. 5:
Apparentenergycharge ECapp

¼
ATP ½  app þ 1=2 ADP ½  app

= ATP ½  app þ ADP ½  app þ AMP ½  app

ð5Þ
Statistics
Differences between mean values for two groups were
statistically analyzed by use of the Mann–Whitney U-test.
P<0.05 was considered statistically significant.
Results and discussion
Detection of metabolites from normal mouse liver tissue
As shown in Fig. 1, MALDI–MS analyses in the negative-
ion mode using 9-AA as the matrix revealed the presence of
many signals including nucleotides on the liver tissue
frozen section with minimal interference from the matrix, as
reported by Edwards and Kennedy [6]. Among these peaks,
16 intense mass peaks were assigned using their exact
masses to nucleotides, nucleotide-sugar conjugates, 2,3-
bisphosphoglycerate (2,3-BPG), taurocholate, and both
reduced and oxidized forms of glutathione. Assignment of
these metabolites was verified by structural analysis of
individual peaks using tandem MS. In the region adjacent
to those for mass-imaging experiments in the same section,
the peaks generated on the tissue surface were identified by
fragmentation using MALDI–QIT-TOF MS [9]. Table 1
summarizes the results of MS and MS
2 analyses. Among
the individual mass peaks of nucleoside-monophosphate,
the ribose-phosphate structure was present (211.0 fragment
ions and neutral losses of adenine, uridine, and guanidine
from precursor ions respectively). Among the peaks of
nucleotide–sugar conjugates, fragment ions derived from
the UDP structure were confirmed (403.0 fragment ions and
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Fig. 1 Typical MALDI mass
spectrum of the mouse liver
collected from the “mass
microscope” a MALDI–IT-TOF
analyzer in the negative-ion
mode. The signals ranging from
m/z=260 to 620 were collected.
Mass spectra of metabolites
were obtained by integrating
10,000,000 consecutive laser
shots (160 shots per subspec-
trum and 62,500 subspectra).
Peaks identified in this study
are labeled; that originating
from the 9-AA matrix is
indicated by an asterisk
Mass imaging of metabolic systems in human colon cancer xenografts 1899neutral loss of each hexose, glucuronic acid, and N-
acetylhexosamines). All the assigned and verified metabo-
lites in Table 1 were compared with commercial standard
compounds under appropriate MALDI and CID tandem MS
conditions.
Intralobular distributions of metabolites in the liver
Figure 2 shows the tissue distribution of metabolites in the
control fed liver of NOG mice. As seen in Figs. 2a and b,
by use of Masson trichrome staining we were able to
distinguish portal and central venules by judging the
presence of bile ducts as a typical structure of the portal
triad. Worthy of note is that the intraluminal space of the
portal (P) and central venules indicated strong signals of
2,3-BPG (Fig. 2d) whereas taurocholate, the taurine-
conjugated form of cholic acid, was evident in bile ducts
(B) adjacent to the portal venules and periportal parenchy-
ma, showing a typical P–P bridging pattern (Fig. 2e). On
the other hand, UDP-glucuronate, a substrate for glucur-
onidization of xenobiotic compounds was localized mainly
in pericentral regions, with a pattern distinct from that of
taurocholate (Fig. 2f). Such an intralobular microanatomical
relationship among periportal and pericentral regions and
the microvessels was well demonstrated by superimposition
of taurocholate (m/z 514.28; green in Figs. 2g and h) with
2,3-BPG (m/z 264.95; red in Fig. 2g) or UDP-glucuronate
(m/z 579.03; red in Fig. 2h), respectively. In contrast, an
intralobular pattern of UDP-HexNAc was distinct, distrib-
uting homogeneously over the whole liver parenchyma
(Fig. 2i). These results suggest that several different
metabolites such as 2,3-BPG, taurocholate, and UDP-
glucuronate visualized by use of this method serve as
reliable markers to distinguish vascular structures and
periportal and pericentral regions in hepatic zonation. Such
results were also consistent with previous observations as
follows. First, 2,3-BPG occurs abundantly in red blood
cells, being at approximately 5 mmol L
−1 [23]. Secondly,
taurocholate is synthesized and excreted to bile canaliculi
around periportal hepatocytes [24, 25], whereas UDP-
glucuronate is biosynthesized predominantly in pericentral
hepatocytes, which had a large capacity for xenobiotic
detoxification [26, 27]. Our approach to analysis of
metabolites at the microscopic level, serves as a powerful
tool to investigate intralobular heterogeneity in metabolic
systems in the liver.
Distinct properties of energy metabolism between cancer
metastases and liver parenchyma
Figure 3 shows representative pictures of high-energy
adenylate phosphates in liver bearing colon cancer metas-
tases under fed conditions. As seen in Figs. 3a and b, the
micrometastases were clearly identified by green fluores-
cence generated by venus-expressing HCT116 cells.
Figure 3c depicts mapping of apparent energy charge that
was calculated from images of AMP, ADP, and ATP
(Figs. 3d, e, and f, respectively). Worthy of note was that
intralobular distribution of these three adenylates appeared
almost homogeneous, whereas the energy charge composed
from these images had a heterogeneous pattern, being
greater at the sites of cancer metastasis than in the liver
Table 1 List of metabolites identified in the study, with their respective deprotonated m/z values and MS
2 ion species in the negative mode
No. [M-H]
−
(m/z)
Fragments observed in MS
2 Formula Identified
1 264.95 246.973, 179.043, 166.955 C3H8O10P2 2,3-Bisphosphoglycerate
2 306.07 254.087, 179.050, 143.048, 158.932, 210.092, 288.858, 120.041 C10H17N3O6S Glutathione (GSH)
3 323.02 211.006, 280.028, 138.983, 158.922 C9H13N2O9P UMP
4 403.00 304.984, 158.907, 384.935, 322.989, 290.931, 272.920 C9H14N2O12P2 UDP
5 482.93 384.927, 272.919, 176.913, 158.905 C9H15N2O15P3 UTP
6 346.05 211.000, 150.985, 134.049, 194.051 C10H14N5O7P AMP
7 426.02 328.044, 134.053, 407.999, 329.037, 272.950, 290.945 C10H15N5O10P2 ADP
8 505.98 408.022, 272.958, 158.922, 176.933, 392.003 C10H16N5O13P3 ATP
9 361.98 210.985, 260.838, 158.908 C10H14N5O8P GMP
10 441.96 343.992, 150.025, 158.909 C10H15N5O11P2 GDP
11 521.91 423.940, 272.924, 176.911, 158.906, 229.979 C10H16N5O14P3 GTP
12 565.03 323.024, 306.072, 402.984, 211.000, 384.977 C15H24N2O17P2 UDP-glucose (UDP-Hexose)
13 579.02 323.027, 402.997, 254.996, 305.011, 210.994 C15H22N2O18P2 UDP-glucuronic acid
14 606.06 384.9445, 402.996, 282.045, 272.956, 323.038, 305.017, 362.008 C17H27N3O17P2 UDP-GlcNAc (UDP-HexNAc)
15 611.14 306.071, 272.086, 338.058, 254.079, 482.103, 304.058, 288.058, 593.121 C20H32N6O12S2 Glutathione, oxidized (GSSG)
1900 A. Kubo et al.parenchyma. So far as judged from the intensities, the
apparent energy charge in the metastatic foci was approx-
imately 0.8, while that in the parenchyma was 0.5–0.7,
suggesting that the foci accelerate generation of high-
energy adenylate phosphates. Of importance were semi-
quantitative values of [ATP]app in the tumor-bearing liver
(Fig. 3f), in the range of approximately 1–2 μmol g
−1 liver,
levels reasonably comparable with previous observations
that determined absolute ATP contents under the snap-
frozen procedures [20, 21]. Because intracellular levels of
ATP are in the mmol L
−1 range, current procedures for data
calibration seemed to reproduce reliable intracellular con-
centrations of metabolites with a rapid turnover.
Glutathione and UDP-HexNAc serve as marker metabolites
enriched in the cancer xenografts
Figure 4 shows representative pictures of UDP-HexNAc,
reduced (GSH), and oxidized (GSSG) forms of glutathione.
As seen in Figs. 4a–c, UDP-HexNAc was predominantly
high in the tumor metastases. GSH and GSSG signals were
also greater in the metastatic foci, but with a different
pattern from that of UDP-HexNAc (Figs. 4d–f). When
focusing on individual foci, UDP-HexNAc and GSH
seemed to be demarcated from each other, suggesting these
molecules occur in a spatially heterogeneous manner in an
individual metastatic focus.
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Fig. 2 In situ mass spectromet-
ric imaging of metabolites in the
control liver of an NOG mouse.
a An optical image of a section
stained with Masson’s trichrome
solutions. The stained section
was adjacent to that was used
for IMS. Scale bar: 500 μm,
B:bile duct, P:portal venule. b
the image with greater magnifi-
cation of the area indicated by
the white square in a. Collagen
fibers in the portal triad were
stained in blue. B:bile duct,
P:portal venule. c Light-
microscopic image of frozen
liver section used in mass
spectrometric imaging that was
captured before matrix applica-
tion. Scale bar: 500 μm. d An
ion image of 2,3-bisphospho-
glycerate (2,3-BPG) at m/z=
264.95 and e taurocholate at
m/z=514.28, f UDP-glucuronate
at m/z=579.03. g The overlaid
image of 2,3-BPG (red) and
taurocholate (green). h UDP-
glucuronate (red) and taurocho-
late (green). i UDP-HexNAc at
m/z=606.06. A representative
set of pictures from four
separate experiments
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Fig. 3 Representative pictures
indicating high-energy adeny-
late phosphates and apparent
energy charge in the tumor-
bearing livers of NOG mice.
a A light-microscopic photo-
graph of intrasplenically injected
HCT116 colon cancer cell
xenografts. Scale bar: 500 μm.
b A green fluorescence image of
the same region shown in (a).
Scale bar: 500 μm. c A heat
map of apparent energy charge
calculated from apparent con-
tents of tumor bearing-liver.
d–f Heat maps of [AMP]app,
[ADP]app, and [ATP]app, respec-
tively. A representative set of
pictures from four separate
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Fig. 4 Glutathione and UDP-
HexNAc as marker metabolites
enriched in hepatic cancer
metastasis. a Light-microscopic
photograph of intrasplenically
injected HCT116 colon cancer
cell xenografts in the liver of
NOG mice. Scale bar: 500 μm.
b A green fluorescence image
of the same specimen shown in
(a). Scale bar: 500 μm. c An
apparent contents map of
UDP-HexNAc at m/z 606.06.
d, e Apparent contents maps of
the reduced type of glutathione
(GSH) at m/z 306.07, and oxi-
dized glutathione (GSSG) at m/z
611.14. f [GSH]app/[GSSG]app
ratio imaging in the same
microscopic field plotted as a
heat map. A representative set
of pictures from four separate
experiments
1902 A. Kubo et al.Figure 5 illustrates semiquantitative comparison of these
metabolites among different groups. As seen in Fig. 5a
showing data collected from CE–MS, amounts of UDP-
HexNAc in the tumor-bearing liver (tumor plus liver) were
significantly greater than those in the control liver. On the
otherhand,amountsofGSHandGSSGwerenotsignificantly
different between the groups. When MALDI–MS intensity
ratios in IMS for these metabolites were analyzed (Fig. 5b),
UDP-HexNAc, GSH, and GSSG were significantly elevated
in the metastatic foci compared with those measured in the
hepatic parenchyma. Such a trend was reproducible in the
calibrated data showing apparent contents of these metabo-
lites (Fig. 5c), suggesting that both forms of glutathione
occurred prominently in the metastatic foci to greater extents
than in the host liver parenchyma.
In the control liver, UDP-HexNAc which is an important
substrate for polysaccharide chains including hyaluronic
acid, was homogeneously distributed over the liver
(Fig. 2i). As seen in Fig. 4, on the other hand, the colon
cancer xenografts exhibited greater accumulation than the
liver parenchyma. Ishimoto et al. and our laboratory have
recently provided evidence that CD44, the hyaluronic acid
receptor expressed on cancer stem cells, is responsible for
stabilization of the cystine transporter xCT that accelerates
uptake of cysteine and glutathione to increase their anti-
oxidative capacity against cell death [28]. Because GSH
detoxifies electrophiles through their conjugation by gluta-
thione S-transferases, such accumulation of the thiol might
contribute to survival of the cancer cells against anti-cancer
reagents [29, 30]. Up to now, it remains still difficult to
visualize amino acids globally by MALDI–MS with high
spatial resolution. Improvement of the spatial resolution in
the current IMS system together with development of the
method to visualize amino acid metabolism deserves further
studies provided that resources and mechanisms for
delivery of amino acids to maintain GSH in cancer cells
are revealed.
Conclusion
Comparison of differences in metabolomic profiles be-
tween control livers and those bearing metastatic foci of
the human colon cancer enabled us to reveal distinct
metabolic features between the two regions. IMS using 9-
aminoacridine enabled us to detect nucleotides, lipids, and
several aminosugars. The metastatic human colon cancer
xenografts displayed remarkable accumulation of UDP-
HexNAc and glutathione in vivo, serving as marker
metabolites. Newly developed IMS combined with CE–
MS measurements serves as a potentially reliable method
to perform intergroup comparison of varied metabolites
among different tissue specimens. Future investigation is
necessary to establish methodology for use of the current
technique in diagnostic medicine.
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Fig. 5 Differences in contents of UDP-HexNAc, and reduced (GSH)
and oxidized (GSSG) glutathione in the tumor-bearing-NOG liver. a
Differences in CE–MS data between the control (open columns) and the
tumor-bearing livers (dark columns) of NOG mice. b The MALDI–MS
signal intensity ratio of UDP-HexNAc, GSH, and GSSG in the
parenchyma (P; open columns) and metastatic foci (M; closed columns)
versus the average MALDI–MS intensity of the ROIs as a whole. Bars
indicate SD. *P<0.05 according to Mann–Whitney U-tests. c Apparent
amounts of UDP-HexNAc, GSH, and GSSG in the parenchyma (P;
open columns) and metastatic foci (M; closed columns). Bars indicate
SD from four separate experiments. *P<0.05, Mann–Whitney U-tests
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